Showing results (111-120 of 289) with videos related to
Sort By:
Pageof 29
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 26, 2003
Tumor size and extent of disease at diagnosis predict the response to initial therapy for papillary thyroid carcinoma in children and adolescentsPatricia A Powers, Catherine A Dinauer, R Michael Tuttle, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancerR Michael Tuttle, Rebecca Leboeuf, Richard J Robbins, et al.The Journal of Clinical Endocrinology and Metabolism|March 30, 2016
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive IodineDenise P Momesso, Fernanda Vaisman, Samantha P Yang, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 26, 2017
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin UnnecessaryJosé M Domínguez, Flavia Nilo, Tania Contreras, et al.Annals of Clinical and Laboratory Science|June 24, 2003
Systemic administration of vascular endothelial growth factor monoclonal antibody reduces the growth of papillary thyroid carcinoma in a nude mouse modelAndrew J Bauer, Aneeta Patel, Richard Terrell, et al.Archives of Endocrinology and Metabolism|May 1, 2019
In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablationLuis Felipe Zavala, María Inés Barra, Roberto Olmos, et al.Archives of Endocrinology and Metabolism|March 28, 2019
Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancerFernanda Andrade, Geneviève Rondeau, Laura Boucai, et al.Histopathology|April 27, 2022
The solid variant of papillary thyroid carcinoma: a multi-institutional retrospective studyBin Xu, Kartik Viswanathan, Lingxin Zhang, et al.Cancer|August 11, 2006
Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entityJeffrey Liu, Bhuvanesh Singh, Giovanni Tallini, et al.Histopathology|March 26, 2024
Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patientsRonald Ghossein, Nora Katabi, Snjezana Dogan, et al.Pageof 29